Aakash Desai: Proteomic Characterization of ADC Target Expression Profiles in SCLC
Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn:
“Excited to share that our team presented research on proteomic characterization of antibody-drug conjugate (ADC) target expression profiles in small cell lung cancer (SCLC) at WCLC24!
Proteomic Characterization of ADC Target Expression Profiles in SCLC
Key takeaways:
• Analysis of 214 samples reveals significant findings on target expressions for ADCs
• These findings provide insights for optimizing therapeutic approaches in SCLC and optimizing patient selection!
We need to continue to push the envelope in personalized oncology for SCLC!”
He also shared:
“Thrilled to have Atulya Aman Khosla present our latest research on protein-based target identification for optimizing bispecific antibody use in non-small cell lung cancer (NSCLC) at WCLC24! International Association for the Study of Lung Cancer
Optimizing Bispecific Antibody Use in NSCLC
Key insights:
• Unique proteomic signatures for LUAD identified
• 5 distinct BsAbs target expression profiles identified
• These insights will help in enhancing drug design for better therapeutic outcomes”
Source: Aakash Desai/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023